Some stroke patients whose life support is withdrawn may have achieved a less-than-ideal but acceptable recovery
American Stroke Association Meeting Report - Abstract TMP83 - Embargoed until 7 a.m. HT/ noon ET on Thursday, Feb. 7, 2013
This news release is featured in a news conference at 7 a.m. HT, Thursday Feb. 7.
- Some patients whose life support ended after bleeding in the brain might have recovered some acceptable function if life support was continued.
- Greater patience and less pessimism may be needed, researchers suggest.
HONOLULU, Feb. 7, 2013 – More than a third of patients who suffer a major bleeding in the brain and have their life support withdrawn might have eventually regained an acceptable level of functioning if life support had been sustained, suggests a new study presented at the American Stroke Association’s International Stroke Conference 2013.
In the United States, 10 percent of the estimated 795,000 strokes each year are intracerebral hemorrhages (ICH). ICH is the most common type of bleeding stroke and it occurs when a weakened blood vessel inside the brain ruptures and leaks blood into surrounding brain tissue, causing neurological damage.
The new study, initially encompassing 590 patients at a Seattle hospital, was designed to see whether “self-fulfilling prognostic pessimism,” might play a part in life-support decisions, said David Tirschwell, M.D., M.Sc., lead author and co-director of the University of Washington Stroke Center at Harborview, in Seattle.
Researchers identified 78 patients whose life support was withdrawn and compared their outcomes with 78 similar patients who were not removed from life support.
Researchers chose a disability rating of “moderately severe” or better as an “acceptable outcome.” Moderately severe could mean patients are unable to attend to their own bodily needs or be unable to walk without assistance, Tirschwell said. He also acknowledged that “acceptable outcome” is up to each individual’s perception and preferences.
At hospital discharge, only 4 percent of matched patients whose life support was withdrawn had an acceptable outcome, compared with 38 percent of the matches who did not have life support withdrawn — suggesting 34 percent of the group whose support was withdrawn might also have had an acceptable outcome if support had been sustained.
“Greater patience and less pessimism may be called for in making these life-and-death decisions,” he said.
For their analysis, the researchers created a “propensity score” indicating the probability that a decision to withdraw life support would be made for a given ICH patient. The propensity score was based on a number of factors: age; functional status before the ICH; level of consciousness; how much bleeding occurred; pre-existing hypertension; diabetes; atrial fibrillation; first temperature measurement on the patient; and whether the patient was intubated for breathing support.
The strongest predictors of life support withdrawal — and the factors most crucial in the patient matching — were measures of the hemorrhage’s severity, Tirschwell said.
“These results are yet another piece of evidence suggesting healthcare providers may be overly pessimistic in their assessments of these patients’ prognoses, leading families to choose withdrawal of life support before the patient has had a chance to recover from their stroke,” Tirschwell said.
Most decisions to withdraw life support are made by next of kin, in consultation with other relatives and with doctors, in the first few days of hospitalization after the ICH, he said. In that time frame, “it would be unrealistic to think the patient has had a chance to attain any measure of recovery,” he said.
While “moderately severe” disability represents far-from-ideal capabilities, “the time of hospital discharge is likely only a couple of weeks after the ICH and recovery is a months-long process, and some of these patients — many even — might recover further,” he said.
Tirschwell said the conclusions are based on the assumption of further recovery, which is known to be a long process and notoriously difficult to predict and the fact that quality of life is subjective. The study, conducted in one hospital, might not reflect practices at other institutions, Tirschwell said.
“The study does a commendable job measuring the effect on patient outcome of the decision-making process, probably the single most difficult factor to model,” said Steven Greenberg, M.D., Ph.D., chair of the International Stroke Conference, Harvard Medical School neurology professor and director Hemorrhagic Stroke Research at Massachusetts General Hospital in Boston.
“The finding that fully a third of ICH patients in whom life support is withdrawn might otherwise survive is staggering” Greenberg said. “The major challenges in interpreting this finding are to determine whether patients can make further improvements after discharge, and if not, whether needing someone to help with walking, washing and other needs is an acceptable quality of life for them.”
Co-authors are Kyra J. Becker, M.D.; Claire J. Creutzfeldt, M.D.; Marisa Gallo, B.S.; and W.T. Longstreth Jr., M.D., M.P.H. Author disclosures are on the abstract.
Funding from the healthcare company Novo Nordisk supported the database used in the research.
Follow news from ASA International Stroke Conference 2013 via Twitter @HeartNews; #ISC13.
Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
Note: Actual presentation is 4:35 p.m. HT/9:35 p.m. ET, Thursday, Feb. 7, 2013.
All downloadable video/audio interviews, B-roll, animation and images related to this news release are located on the right column of the release link. Video clips with researchers/authors of studies will be added to the release links after embargo.
ASA News Media in Dallas: (214) 706-1173